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Abstract: A Next Generation Personal Education Program (PEP-NG) that captures self-reported 
medication behaviors and delivers a tailored educational intervention on a touchscreen interface 
was piloted with 11 adults with hypertension, aged 45–60 years, in a worksite setting. A time 
series design with multiple institution of treatment (four visits over three months) was employed. 
Blood pressure (BP), self-medication behaviors, self-efficacy, and knowledge for avoiding adverse 
self-medication behaviors were assessed at each of four visits. Satisfaction was assessed once 
at visit 4. Measures pre-PEP (visit 1) to visit 4 were compared with paired t-tests. The adverse 
self-medication behavior risk score decreased significantly from visit 1 to visit 4 (p  0.05) with 
a medium effect size. Both knowledge and self-efficacy for avoiding adverse self-medication 
behaviors increased significantly (p  0.05) with large effect sizes. All six participants not at BP 
goal (140/90 mmHg) on visit 1 were at goal by visit 4. User satisfaction was high as assessed 
by both quantitative measures and qualitative interviews. These positive results suggest the PEP 
could play a central role in worksite wellness programs aimed at workers with hypertension.
Keywords: hypertension, worksite, information technology, tailored intervention
Introduction
Over 72 million Americans (33%) have hypertension and another 31% of Americans 
are prehypertensive.1,a Individuals who are normotensive at age 55 are estimated to 
have a 90% future lifetime risk for developing hypertension.2 Hypertension results in 
more visits to providers than any other condition and, despite frequent health care visits, 
patients with hypertension often do not achieve target blood pressure (BP) readings.3–7 
Nurse-run worksite wellness programs offer an opportunity for BP monitoring and 
educational interventions targeted to adults with, or at risk for, hypertension. The 
purpose of this study was to pilot the next-generation of a network-based Next 
Generation Personal Education Program (PEP-NG) that captures the user’s self-
reported medication behaviors and delivers a tailored educational intervention aimed 
at improving medication adherence and reducing adverse self-medication behaviors 
in workers aged 45–60 years.
Background
Poor adherence to antihypertensive regimens is often cited as the principal reason 
for inadequate BP control and has been associated with preventable adverse drug 
aHypertension is defined as a systolic blood pressure (SBP)  139 mm Hg or a diastolic blood pressure 
(DBP)  89 mm Hg. Prehypertension is defined as a SBP of 120–139 mm Hg or a DBP of 80–89 mm Hg.1Patient Preference and Adherence 2009:3 278
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events and hospitalization at an estimated annual cost of 
over US$100 billion.1 Patient adherence is greatest five 
days pre- and five days post-appointment with the health 
care provider and usually tapers off significantly within 
30 days: the so called “white coat adherence.”8 Authors of 
a Cochrane systematic review of recent clinical trials aimed 
at improving patient adherence to antihypertensive therapy 
concluded that none of the trials have yet demonstrated 
large long-term improvements in either adherence, provider 
visits, or health outcomes.9 For example, in two recent studies 
of US veterans with hypertension,10,11 aged 30–87 years, 
patient education in the form of phone calls and teaching 
modules did increase patient achievement of BP goals but 
in a similar study adherence fell to pre-intervention levels 
when the intervention was discontinued.12
In addition to poor adherence to antihypertensive regimens, 
adverse self-medication behaviors with over-the-counter 
(OTC) medications, supplements, and alcohol can conflict 
with antihypertensives and contribute to poor BP control 
and associated costs.13–17 Poly-pharmacy issues arise because 
often patients with hypertension have comorbid diseases 
(eg, osteoarthritis) and select an inappropriate OTC analgesic 
such as nonsteroidal anti-inflammatory drugs (NSAIDs). 
NSAIDS (eg, ibuprofen) counteract the efficacy of antihyper-
tensive agents and increase BP when taken concurrently.18,19 
They also antagonize the antiplatelet effects of low-dose 
aspirin.20
Addressing both adherence and adverse self-medication 
practices is an important step toward reducing the risk of 
potential adverse drug interactions (PADI). Failure to identify 
and remediate poor adherence and adverse self-medication 
behaviors often results in intensified pharmacotherapy with 
increased doses of antihypertensives and additional antihy-
pertensive agents. This increases the overall cost of treatment 
as well as escalates the risk of adverse antihypertensive drug 
side effects.21,22
An evidence-based mechanism to maximize access to 
medication instruction and provider advice is critical to 
maintaining BP control in patients with hypertension.6,16,23 
Behavior change stems not only from an increase in 
knowledge, but an increase in one’s perceived ability to 
apply that knowledge correctly, termed self-efficacy by 
Bandura.24 Our previous educational interventions aimed at 
increasing older (aged 60 years and over) adults’ knowledge 
and self-efficacy for avoiding adverse self-medication 
behaviors, demonstrated positive clinical outcomes in terms 
of improved BP control, and reduced self-report of adverse 
self-medication behaviors.25–27 Review of the literature 
concerning educational intervention programs for adults with 
hypertension indicates that there are gaps for persons in the 
age range of 45–60 years. As this age group has been found 
to have a lower adherence to antihypertensive regimens than 
older adults,28 interventions aimed at workers with hyper-
tension could help improve clinical outcomes. Results of a 
pilot test of the PEP-NG with adults with hypertension, aged 
45–60, at a university worksite are reported herein.
PeP-Ng
The Personal Education Program (PEP) is an educational 
intervention previously been shown to be effective in 
improving knowledge and self-efficacy and reducing adverse 
self-medication practices in older adults with hypertension.25,26 
The PEP was enhanced to PEP-NG by incorporating the 
outcome instruments (previously administered by paper 
and pencil, eg, demographics, medication use, knowledge, 
self efficacy, satisfaction) in the interface. The PEP-NG is 
a risk profiling system that captures and assesses complex 
self-medication behaviors of patients and assesses their related 
knowledge and correct medication-taking self-efficacy. 
Patients access the program via a wireless tablet personal 
computer (PC) and a stylus interface to answer a set of 
medication regimen (prescription and OTC) and self-
medication practice questions. A rules engine selects three 
adverse self-medications behaviors (with the highest risk 
scores) and delivers tailored interactive educational content 
including “medicine facts,” animations that illustrate the 
consequences of the adverse behaviors identified, “what you 
can do” offering corrective strategies, and interactive ques-
tions that allow the user to apply information learned. If fewer 
than three adverse behaviors are identified, the PEP-NG 
delivers a set of up to three default statements dealing with 
medication adherence, OTC pain relievers (that can be safely 
taken with antihypertensives), and dangers of combining 
different types of pain relievers (prescription or OTC). 
Summaries of self-reported symptoms, medication use 
(including frequency/time), adverse self-medication behaviors 
(along with a thumbnail illustration from the animations), and 
corrective strategies are printed for the user to take home for 
self-study. These summaries are also available to the health 
care practitioner prior to the visit for use in providing correc-
tive or reinforcing guidance, and in oversight of adherence 
behaviors for improved outcomes.
A detailed description of the PEP and PEP-NG develop-
ment, results of formative evaluation during development and 
formal usability testing with older adults and primary care 
providers (advanced practice nurses) have been published Patient Preference and Adherence 2009:3 279
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elsewhere.29–32 Text (written at a grade 6 Flesch–Kincaid 
reading level) and background colors, contrast, graphics 
and animation style (including speed of the display, object 
movements and animation sequences) suit the visual and 
cognitive characteristics of older adults.29–31,33 Extrawide 
scroll bars and drop-down menus (displayed in blocks of 
eight lines) ease use for those with stiff joints and/or fine 
tremor and an animated clock enables the user to easily select 
the time, frequency, and dosage of medication.30
An Access (Microsoft, Redmond, WA, USA) database 
receives the entered data which includes user, site and pro-
vider identity codes, health literacy score, BP (measured 
and entered by the provider), demographic data, medical 
conditions, patient reported symptoms, knowledge, self-
efficacy, and medication use (including frequency and time 
of administration). The self-medication behaviors are scored 
according to a previously validated weighting scheme.26 User 
action is date/time-stamped. Data is transferred to the data-
base via a virtual private network, which meets or exceeds 
the Health Insurance Portability and Accountability Act 
(HIPAA) requirements and the European Union Directive 
95/46/EC and in accordance with International Organization 
for Standardization (ISO 9100) international standards.34–37
Results of formal usability tests suggest that the final 
PEP-NG prototype permitted older adult users to navigate the 
PEP with minimal errors and subject burden with a mean time 
for interface use (N = 10) of 33.08 ± 7.65 minutes. Ratings for 
system usefulness and satisfaction with the PEP were high for 
both older adult users and advanced practice nurses.31,32
Methods
The PEP-NG was beta-tested in a worksite setting 
with 11 individuals with hypertension (aged 45–60 years) 
over a four visit, three-month period. The specific aims 
were for participants to: 1) achieve target BP readings; 
2) increase knowledge of potential adverse self-medication 
practices as measured on the knowledge score; 3) increase 
self-efficacy for avoiding adverse self-medication practices 
as measured on the self-efficacy score; 4) reduce self-
reported adverse self-medication behaviors as measured 
on the adverse self-medication behavior risk score; and 
5) demonstrate satisfaction using the PEP.
Participants
The University Human Subjects Review Board approved 
the study and all members of the research team completed 
online research ethics training. All university nonfaculty 
and nonprofessional staff received recruitment flyers for 
the study. The study was conducted in a private office in 
a university research center that houses interdisciplinary 
health research studies. A student nurse researcher met 
with each potential participant to describe the study, obtain 
informed consent, and assess participants for inclusion 
criteria. Participant inclusion criteria were: 1) not previously 
involved in a PEP or PEP-NG study, 2) at least age 45 but not 
more than age 60 (by self-report), 3) a health literacy score 
of at least 44 (6th grade) as measured by the Rapid Estimate 
of Adult Literacy in Medicine (REALM) tool,38 4) taking 
prescribed antihypertensive medication, and 5) independent 
physical and cognitive functioning including the ability 
to: a) perform telephone, shopping, travel arrangements, 
medication taking, and manage finance activities indepen-
dently on the Instrumental Activities of Daily Living Scale,39 
b) answer six of 10 items on the Short Portable Mental 
Status Questionnaire,40 and c) be living independently. 
Participants also needed to demonstrate a visual acuity of at 
least 20/100 (with corrective lenses if needed). Participants 
were requested not to participate in another research study 
related to their health while enrolled in this one.
Participant information was coded by a random ID 
number selected by the student nurse researcher from a 
computer-generated list of random numbers. The faculty 
researchers analyzing the data could not trace a participant 
ID to identify a specific patient or link private health informa-
tion to study participants. Only the student nurse researcher 
had access to the participant name and ID. The tablet PCs 
were set up so that the PEP-NG was the only site that could 
be accessed on the tablet (ie, no other Internet connection 
was available).
Measures
The knowledge, self-efficacy, adverse self-medication 
behavior risk and satisfaction scales were previously vali-
dated and their psychometric properties described.14,25,26,30 
The knowledge scale has 14 multiple-choice items, each with 
one correct response and three distracters. The Knowledge 
score is the percent correct. Items test both knowledge and 
application concerning potential interactions with antihy-
pertensives following self-medication with OTC agents, 
supplements, or alcohol.
The self-efficacy scale is a 12-item instrument with 
statements related to confidence in selecting appropriate 
OTC agents and supplements and avoiding drug interactions 
arising from self-medication behaviors. It has five-point self-
report response categories that range from 1, “Not sure” to 5, 
“Totally sure.” Responses are summed and divided by the Patient Preference and Adherence 2009:3 280
Neafsey et al Dovepress
submit your manuscript | www.dovepress.com
Dovepress 
number of items answered, so that the overall score is not 
affected by omitted items and is expressed in the original 
fiv-point metric.
Adverse behaviors are identified from questions that 
address use (in the past month) of medications to treat high 
BP and use of OTC agents, supplements, and alcohol for 
problems often self-managed with nonprescription agents 
(eg, pain, fever, colds or sinus, allergies, sleep, indigestion, 
gas, constipation). Users are also asked if they drank 
alcoholic beverages, smoked or used nicotine, or took any 
vitamin or mineral supplements (including what, when and 
how frequently each was taken). A an expert panel (following 
a modified Delphi method) rated a list of self-medication 
behaviors on a five-point scale from 1, “Very unlikely” 
to 5, “Very likely” to cause an adverse outcome. The mean 
expert rating was used to determine the importance weight 
for each adverse behavior in the rules engine. The adverse 
self-medication behavior risk score is the weighted sum of 
the scores for the adverse behaviors identified.
The satisfaction scale is a 14-item instrument. Eight items 
address the ease of program use, program content, and 
suitability of program content, and six items address the 
perceived likelihood of making behavior change following 
program use. The five-point Likert-type scale ranges 
from 1, “Strongly disagree” to 5, “Strongly agree.” Ratings 
are summed and divided by the number of items answered, 
so that the overall satisfaction scale is not affected by omitted 
items and is expressed in the original five-point metric.
Procedure
The PEP-NG was piloted in a university worksite setting 
from January until June, 2008, using a time series design 
with multiple institution of treatment (use of the PEP-NG on 
four visits over three months). Two student nurse researchers 
were trained to follow the study protocol and their skill 
in taking BP measurements (with both large and small 
cuffs)41 was verified by a master’s prepared registered nurse 
(MS, RN) in the graduate advanced practice nursing program. 
They were supervised by a board-certified APRN and director 
of the university graduate adult primary care program that 
prepares students for advance practice as adult nurse practi-
tioners with an APRN license.
Each participant met with one of two student nurse 
researchers once a month for four months in a private 
conference room in the university interdisciplinary health 
research center. Participants brought all of their medications 
(including supplements) to each visit. BP was recorded at the 
beginning of each visit. On first visit, participants used the 
PEP-NG to complete the demographic questionnaire and all 
of the remaining scales except the satisfaction instrument. 
The demographic questionnaire was omitted on subsequent 
visits. At end of PEP-NG use on the fourth visit, participants 
completed the patient satisfaction instrument on the PEP-NG 
in addition to the other scales. After each PEP-NG use, 
the participant met with the student nurse researcher for 
approximately 10 minutes to go over the printout that listed 
symptoms, reported adverse self-medication behaviors, and 
corrective strategies suggested by the PEP-NG. Each partici-
pant was given a US$10 grocery gift card at the end of each of 
the first three visits and a US$25 grocery gift card at the end 
of the 4th visit to compensate for their time in the study.
Following the four visits, participants were invited to con-
tribute in follow-up interviews. Six responded to the invitation 
and agreed to be interviewed. Interviewed participants were 
given an additional US$10 grocery gift card to compensate 
for their time in the interview. A student nurse researcher met 
individually with each participant for a 20 minute interview. 
With a set of 15 open-ended questions, participants were 
asked about their prior computer usage, their self-perceived 
knowledge about their medications, their confidence in taking 
their medications as prescribed, changes in their medication 
usage during the study, and ideas on how to improve the 
PEP-NG program. All interviews were tape recorded and 
the data were later transcribed verbatim by the student nurse 
researcher/interviewer.
Data analysis
SAS software (v. 9.1.3; SAS Institute, Cary, NC, USA) was 
used for data analysis. Descriptive statistics were tabulated 
for user age, education, health literacy score, knowledge 
score, self-efficacy score, adverse self-medication behavior 
risk score, BP, and satisfaction scores. Correlations were 
conducted between user age, education, and health literacy 
score and outcome measures of BP and knowledge, 
self-efficacy and self-medication risk scores to determine if 
the PEP-NG outcomes were associated with user demographic 
variables. Outcome measures were also correlated with each 
other to determine if knowledge and/or self-efficacy was 
related to self-medication behaviors and if self-medication 
behavior was related to BP.
We had missing data for one participant on visit 2 who 
was unable to make the appointment and missing electronic 
data on visit 3 (due to electrical connectivity issues) for one 
participant (we did have all BP data for this participant). 
Consequently, we employed paired t-tests to analyze the 
data on visits 1 and 4 in this small scale, exploratory pilot. Patient Preference and Adherence 2009:3 281
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An a priori alpha for statistical significance was set at 0.05. 
Effect sizes (Cohen’s d) were calculated using the standard 
deviations comparing visit 1 with visit 4.42
Content analysis guided analysis of the interview data.43 
This qualitative research method involves identifying, 
categorizing, and labeling the patterns in the data. Transcripts 
were reviewed in detail. Recurring ideas were analyzed 
and sorted into categories.
Results
Participant characteristics
Fifteen participants (12 women, 3 men) responded to the 
flyers to participate in the study. Three women dropped out 
of the study before the consent process; one man dropped 
out of the study following the consent process, but before 
visit 1. Personal time constraints were cited as the reasons 
for not following through on study participation. The final 
sample consisted of 11 participants (9 women, 2 men), all of 
whom completed the study. All of the participants reported 
they were Caucasian; one participant indicated he/she 
was also Native American. The mean age was 55.5 ± 2.12 
(range 53–57) years. The mean length of education was 
15.5 ± 0.7 years. All participants had some post-high school 
education or training and three were college graduates. 
All REALM scores were 66 out of a possible score of 66, thus 
all were able to read at high school level. Ten participants 
reported that their primary care provider is a doctor and one 
reported that a nurse practitioner is the primary care provider. 
All of the participants reported they were PC and Internet 
users. Eight participants reported using a PC daily and three 
reported using a PC five days per week. Reported PC use 
averaged 5.38 hours per day (range 3–6 hours).
At the beginning of the study, 10 of the 11 participants 
rated their health over the past year as 4 (“good”), one 
rated health as a 3 (“average”) on a five-point scale. The 
risk of a PADI is increased in individuals having three or 
more chronic illnesses, taking five or more medications per 
day, with more than 12 medication doses per day, a history 
of nonadherence, or taking a drug requiring therapeutic 
monitoring.44 Ten of the participants (91%) in this study were 
at risk for a PADI on visit 1. Four (36%) reported having 
three or more chronic illnesses (range 1–5) and two of these 
reported taking five or more prescription medications a 
day. The average number of prescription medications taken 
daily was 2.55 ± 1.24 (range 1–6) with two (18%) taking 
five or more prescription medications a day. When OTC 
medications and vitamin/mineral/herbal supplements were 
included, the average number of medications taken daily 
in this study was 9.36 ± 7.78 (range 3–31) with nine of the 
11 (82%) participants taking five or more agents daily and 
10 participants (91%) taking 12 or more medication doses 
per day. Ten (91%) of the participants reported consuming 
an alcoholic beverage daily. Three of the four participants 
who reported three or more chronic illnesses and took five 
or more prescription medications daily and took more than 
12 medication doses per day were not at the Seventh Report 
of the Joint National Committee on Prevention, Detection, 
Evaluation, and Treatment of High Blood Pressure (JNC-7) 
BP target on visit 1. Two of these three participants also 
reported less than daily adherence with their antihypertensive 
medications.
Table 1 shows the study outcome results for BP, 
knowledge, self-efficacy and adverse self-medication 
behavior risk scores.
Blood pressure
The JNC-7 goal of 140/90 mm Hg1,4,45 was met by five 
participants (45%) on visit 1 and all 11 participants on visit 4, 
thus the aim for all particpants to attain the JNC-7 goal by the 
end of the study was achieved. The mean decline in systolic 
BP was -9.27 ± 15.85 mm Hg (p = 0.0811) and the mean 
decline in diastolic BP was -4.0 ± 8.5 mm Hg (p = 0.151) 
from visit 1 to visit 4. Neither decline in BP was statistically 
significant (see Table 1).
BP declined over the four visits for all of the 6 (55%) 
participants not at the JNC-7 target of 140/90 mm upon 
study entry. For these participants, the mean preinterven-
tion (visit 1) systolic BP was 149.3 ± 12.75 and the mean 
systolic BP on visit 4 was 130.0 ± 15.8, a statistically 
Table 1 Results of PeP-Ng beta test in workers with hypertension
Outcome Pre-visit #1 Visit #4 tb p Cohen’s d
Variablea  Mean 
(SD)
Mean 
(SD)
        
systolic BP (mm hg) 137.1 
(17.81)
127.8c 
(13.01)
1.94 0.0811 -0.60
Diastolic BP (mm hg) 87.45 
(10.04)
83.45c 
(3.80)
1.55 0.151 -0.53
Knowledge score % 44.15 
(20.16)
62.70 
(21.36)
3.28 0.0112 0.89
Self-efficacy score 2.08 
(0.61)
3.28 
(0.52)
6.55 0.0002 2.12
Adverse self-
medication behavior 
risk score
17.45 
(10.23) 
12.18 
(5.32) 
1.82 0.048 0.66
Notes: an = 11; bdf = 10; cAll 11 participants met the JNc-7 goal by visit 4.Patient Preference and Adherence 2009:3 282
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significant decrease (t = 3.18, df = 5; p = 0.0246). The mean 
pre-PEP (visit 1) diastolic BP was 94.33 ± 6.37 and the mean 
diastolic BP on visit 4 was 85.66 ± 3.66, also a statistically 
significant decrease (t = 2.89, df = 5, p = 0.0341). The mean 
decline in systolic BP for the six participants not at goal 
at visit 1 was -19.33 ± 14.89 mm Hg with a large effect 
size (Cohen’s d = -1.34, r = -0.56). The mean decline in 
diastolic BP was -8.66 ± 7.33 mm Hg from visit 1 to visit 4 
and was accompanied a large effect size (Cohen’s d = -1.67, 
r = -0.64) (see Table 2).
Knowledge and self-efficacy
Results of a paired samples t-test revealed that the increase 
in the knowledge score was statistically significant with a 
medium effect size. The increase in self-efficacy scores was 
statistically significant with a large effect size. knowledge 
and self-efficacy scores were not significantly correlated 
with each other.
Behavior risk score
The decline in the adverse self-medication behavior risk 
scores was statistically significant with a medium effect size. 
When asked how often they took their antihypertensive medi-
cation, two participants (18%) responded either “less than 
daily” or “when I remembered to take it” on at least one visit; 
both of these were above the JNC-7 goal pre-visit 1. The most 
common reported adverse self-medication behavior on visit 1 
was taking an NSAID that can elevate BP and counteract the 
efficacy of antihypertensives and low-dose aspirin (64% of 
participants, 67% of those not at JNC-7 goal). The second 
most common behavior was taking a decongestant that 
can elevate BP46 (54% of participants, 50% of those not at 
JNC-7 goal). One of the participants not at the JNC-7 goal 
reported consuming three or more alcoholic drinks per day, 
a practice that can elevate BP.1,4 None of the participants 
above the JNC-7 goal pre-visit 1 reported use of NSAIDS on 
visit 4. All reported using acetaminophen for pain. Two of 
the three participants not at goal pre-visit 1 and who reported 
use of a decongestant, discontinued use by visit 4.
Neither user age, nor years of education, nor REALM 
score were significantly correlated with BP, knowledge, 
self-efficacy, or adverse self-medication behavior risk score. 
The adverse self-medication behavior risk score was not 
significantly correlated with BP, knowledge, or self-efficacy 
scores.
satisfaction
The overall mean satisfaction score was 4.21 ± 0.30 on the 
five-point, nine-item scale. Participants also indicated their 
degree of agreement with statements concerning their intent to 
change behaviors after using the PEP-NG. The overall mean 
intent to change score was 4.30 ± 0.52 on the five-point, six-item 
scale. All of the participants either agreed or strongly agreed 
with the statements “This program helped me want to change 
how I use medicines” and “This program helped me think of 
questions to ask my doctor.” All of the participants either agreed 
or strongly agreed with the statement “After using this program I 
will make some changes in how I use medicines” and 10 (91%) 
of the participants agreed with the statement “After using 
this program I will change when I take some medicines.”
content analysis of qualitative interviews
The first category identified from the interview transcripts 
was comfort with computer usage. All of the interviewed 
participants expressed being comfortable using computers 
prior to participating in the study. No changes in their 
attitudes or thinking toward computer usage occurred after 
using the PEP-NG. The participants described the PEP-NG 
as “easy to use”, “self-explanatory”, and “user friendly.”
A second category, new medication knowledge, was 
evident among the participants. Four of the six (66%) 
interviewed participants said they thought they under-
stood their medication well before beginning the program. 
One participant acknowledged, “I don’t understand them 
[medication purpose] all that well,” while another claimed to 
understand their medications “perfectly” before beginning 
Table 2 Mean blood pressure (mm hg) values
All participants (N = 11)
Visit Blood pressure
Systolic Diastolic
  Mean (SD) Mean (SD)
1 137.1 (17.80) 87.5 (10.0)
2 128.5 (14.34) 89.7 (10.8)
3 129.1 (11.32) 84.9 (10.6)
4 127.8 (13.0) 83.4 (3.8)
Participants not at goal (140/90) on Visit 1 (N = 6)
Visit Blood pressure
Systolic Diastolic
  Mean (SD) Mean (SD)
1 149.3 (12.7) 94.3 (6.3)
2 134.7 (15.5) 96.16 (6.3)
3 129.0 (13.7) 88.3 (11.1)
4 130.0 (15.8)* 85.6 (3.6)*
Note: *Significantly different from visit 1 (p  0.05).Patient Preference and Adherence 2009:3 283
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the program. The mixed sentiments of  the participants 
indicate a disparity of knowledge prior to the study. All 
six participants stated the PEP-NG helped them learn 
about their medications. The participants enjoyed learning 
about their medication interaction and expressed interest 
in learning about the interactions of their other classes 
of medications. Most mentioned increase knowledge of 
medication interactions, with special concentration on 
NSAID pain relievers. One affirmed, “I learned that the 
Advil (ibuprofen) I was taking was interacting with my 
BP medication and now I take Tylenol (acetaminophen).” 
An improvement in knowledge related to alcohol intake and 
the negative effect on BP medication also was mentioned. 
One more medication the participants gained knowledge 
about was the ineffectiveness of Vitamin E in cardiopro-
tection.47
A third category was wariness of medication interactions. 
All participants said their knowledge of medication changed 
as a result of the PEP-NG program. Five out of six (84%) 
said their views changed by learning about the interactions 
between their medications and supplements. The participants 
acknowledged they became “more wary” and aware of the 
conflicts between prescription drugs and supplements, as 
well as OTC drugs. One person noted:
“I think I’m more wary of how other things will interact with 
them. I mean just reaching up in the cabinet for OTC pain 
relievers. I never thought OTC and prescription stuff were 
related in any way or form, or would be affected by the other 
so much. And now I don’t take anything without saying, 
‘Wait a minute. Is there a problem?’ There were a couple 
of surprises that I learned in that study that I shouldn’t be 
taking, what would counteract what I would be taking for 
blood pressure medicine.”
Another person said, “I changed some of my antacids, 
headache medication, or pain medication. I try to take Tylenol 
now instead of the other stuff.”
The fourth category was making medication changes. 
Participants were asked if they changed the way they took 
their medicines after being in the study. Half said they 
already began or had started changing the time of day they 
were taking their medicine: “between the morning and night 
instead of all in the morning.” One participant even noted 
a marked decrease in BP from changing the timing of the 
medication. Another mentioned waiting two hours after 
taking antihypertensives to take a supplement or an OTC 
medication in order to decrease the negative interactions. 
One participant changed taking antacids, “I would be popping 
Tums (calcium carbonate) at the wrong time of day…not 
even thinking about it. I was thinking ‘Tums are Tums.’ You 
can eat them like candy.”
Changes or recommendations to improve the PEP-NG 
were queried. No major changes were recommended. Half 
stated they wanted more drug and dietary supplement choices 
to choose from on the user interface. Although the main 
focus was on drug/alcohol interactions with antihypertensive 
medications, several of the participants would have liked to 
learn how OTC drugs and alcohol influenced the medications 
they took for other health issues. Another change suggested 
by the participants involved the tutorial and animations. The 
PEP-NG software was originally designed for adults over the 
age of 60 and features a tutorial at the beginning of the user 
session. This sample, aged 45 to 60 years, found the tutorial 
repetitive. They enjoyed the animations, but recommended 
to make “the videos a little quicker for those of us who are 
more computer literate than others.”
Discussion
Findings from this beta test of the PEP-NG in a worksite 
setting suggest high user satisfaction in the group aged 
45–60 years. Participants also indicated that they were likely 
to make changes in their self-medication behaviors following 
use of the PEP-NG.
The PEP-NG had a medium effect size in increasing 
knowledge and a large effect in increasing self-efficacy for 
avoiding adverse self-medication behaviors. Knowledge 
scores were not significantly correlated with self-efficacy 
scores, a consistent finding in our previous studies with 
over 170 participants25–27 and expected if knowledge and 
self-efficacy are separate domains as theorized by Bandura.24 
Behavior risk scores for medication errors decreased 
significantly. These results are similar to those from a 
previous beta test of the PEP-NG with 11 older adults aged 
65–97 years.27 Historical control data with 60 older adult 
participants receiving face-to-face education only without 
the PEP intervention showed no changes in knowledge, 
self-efficacy, or behavior risk over time.25,26
All of the participants met the JNC-7 BP target by the 
end of the study suggesting that the intervention reported 
herein (that included monthly worksite BP checks, referral 
to the primary care provider when elevated BP readings 
were identified, and use of the PEP-NG program) can help 
identify workers not meeting BP goals and shed light on 
reasons for BP elevation such as poor adherence and/or 
adverse self-medication practices. This information can be 
shared (via the printout) with both the worker and the primary 
health care provider.Patient Preference and Adherence 2009:3 284
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A report for the Agency for Healthcare Research and 
Quality (AHRQ) documented mean reductions in systolic BP 
and diastolic BP as 4.5 mm Hg and 2.1 mm Hg, respectively, 
across all studies and strategies examined.48 The present study 
found BP reductions of over 5 mm Hg for both systolic and 
diastolic BP for all six participants not meeting the JNC-7 
goal upon entry to the study. Two of the six participants not 
at the JNC-7 goal on visit 1 had a provider-initiated change 
in their medication. Both of these participants had a BP of 
greater than 160/100 on visit 1 and were referred immediately 
to their primary health care providers, who subsequently 
changed their antihypertensive regimens. Whether the 
elevated BP in these two participants would have been 
identified and attended to had the participants not been in the 
study is unknown. These results indicate that the PEP-NG 
intervention (which includes monthly BP measurements) 
at the worksite may offer a beneficial adjunct to the usual 
care of adults aged 45–60 years with poorly controlled 
hypertension.
The 1998–1999 Sloane telephone survey of a random 
sample of 2590 US adults reported 7% of adults aged 
45–60 years were taking five or more prescription medica-
tions per day and 14% were taking five or more medications 
a day when OTC agents were included.49 Participants with 
hypertension in the current study took more daily medica-
tions than the general population of adults aged 45–60 years 
surveyed in the Sloane study. The differences may be due 
to sampling error given the small size of the present study. 
However, our prior studies also found greater self-medication 
use by older adults with hypertension compared to the general 
older population surveyed in the Sloane study.14,27
Measurement of patient medication adherence remains 
problematic. Blood assays and electronic adherence moni-
toring devices are costly and pharmacy refill rates and pill 
counts are labor-intensive.8,50,51 The cardiovascular risk 
associated with self-reported nonadherence (ie, answering 
a single survey question, “In the last month, how often did 
you take your medications as your doctor prescribed?”) has 
been shown to be as great as that from smoking or diabetes.52 
The simple self-report approach taken by the PEP-NG may 
underestimate adherence, but it does identify nonadherence 
when it is reported and may foster a subsequent discussion 
between patient and provider about the reasons for nonad-
herence as well as strategies for improved adherence to the 
medication regimen.
The PEP-NG was originally designed for the psychomo-
tor skills and cognitive characteristics of older adults. The 
qualitative interviews reported herein are important because 
they support the usability of the PEP-NG in adults aged 
45–60 years. These younger individuals with hypertension 
found the PEP-NG program engaging and informative. 
If themes such as “the program is boring” or “the program 
takes too much time” had been identified, the PEP-NG would 
need to undergo formal, iterative usability tests with this age 
group during extensive revision. Simple modifications were 
recommended: an expanded OTC and supplement database 
and a user-friendly speed adjustment for the animations.
The limitations of this pilot study (single worksite setting, 
student nurse providers, small, homogeneous Caucasian 
sample with high levels of health literacy, time series design 
without a control group or randomization, and self-reported 
medication use) prevent generalization to the population of 
adult workers with hypertension. However, the effect sizes 
attained are positive findings that support our plan to scale 
the PEP-NG intervention for a large, controlled effectiveness 
trial in a worksite setting.
Conclusions
The pilot data reported here suggest that the PEP-NG may 
help adult workers with hypertension and a high risk of PADI 
identify behaviors that they can change in order to improve 
adherence to their medication regimen and reduce adverse self-
medication behaviors. Our previous usability tests (N = 48 
sets of observations) demonstrated that BP measurements did 
not change from the immediate pre- to the immediate post-
PEP use indicating that the PEP interface experience neither 
induced anxiety nor fostered relaxation.27,31 Thus, the PEP-NG 
appears to make good use of the user’s waiting time. The 
improvements in knowledge, self-efficacy, self-medication 
behavior, and high satisfaction found in this pilot suggest that 
the PEP-NG could play a central role in worksite wellness 
programs aimed at workers with hypertension. Following 
revision of the animations to include a speed control in 
order improve the interface experience for younger adults, a 
large-scale controlled efficacy trial comparing the PEP-NG 
intervention with usual care in a nurse-run worksite wellness 
program is planned. If successful, both in terms of workflow 
and health outcomes, the PEP-NG could be an important asset 
in comprehensive employee health programs as described in 
the goals of the US Department of Health and Human Services 
document, Healthy People 2010.53
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